BoardBase

Ticker

OXB

FTSE Rank

277

20

People

7Board Members

13Executives

Country: United Kingdom (UK)
Industry: Pharmaceuticals
Website: www.oxfordbiomedica.co.uk

Board


	Colin Bond	Non-Executive Director	66
	Heather Preston	Non-Executive Director	60
	Kay Davies	Non-Executive Director	75
	Laurence Espinasse	Non-Executive Director	N/A
	Namrata Patel	Independent Director	N/A
	Peter Soelkner	Vice Chairman of the Board	N/A
	Roch Doliveux	Chairman of the Board	70

Executives


Frank Mathias	CEO	Chief Executive Officer and Director
Laetitia Botrel	N-1	Vice President, Commercial Operations & Technical Excellence
Amanda Collett	N-1	Vice President, Head of Supply Chain
Thierry Cournez	N-1	Chief Operating Officer
Lucinda Crabtree	N-1	Chief Financial Officer and Director
Lisa Doman	N-1	Chief People Officer
Ify Iwuchukwu	N-1	Vice President, Process and Analytical Development
Melanie Kearney	N-1	Senior Vice President, Global Head of Quality
Kyriacos Mitrophanous	N-1	Chief Innovation Officer
Sébastien Ribault	N-1	Chief Business Officer
Michelle Robins	N-1	Vice President, Information Systems
Sabine Sydow	N-1	Chief of Staff
Natalie Walter	N-1	General Counsel

Former Officers and Directors


Tracey Graham	Chief Tech/Sci/R&D Officer2010-11-08 -> N/A	2010-11-08	N/A
James Willis	Human Resources Officer2015-12-31 -> N/A	2015-12-31	N/A
Robert Henke	Director/Board Member2019-06-23 -> 2025-10-19	2019-06-23	2025-10-19
Stuart Paynter	Director of Finance/CFO2017-08-28 -> 2024-09-01 Director/Board Member2017-08-28 -> 2024-09-01 Public Communications ContactN/A -> N/A	2017-08-28	2024-09-01
John Bason	Director/Board Member2008-07-31 -> 2022-05-26 Chief Executive Officer2008-09-30 -> 2022-01-27	2008-09-30	2022-05-26
Andrew Heath	Director/Board Member2009-12-31 -> 2021-05-26 Independent Dir/Board Member2009-12-31 -> 2021-05-26	2009-12-31	2021-05-26
Paul Barker	Corporate Officer/Principal2014-08-31 -> 2016-08-30	2014-08-31	2016-08-30